Biotechs around the world are sprinting to develop a viable coronavirus vaccine. But which will get to the finish line first? In this episode, Business Insider’s healthcare reporter Andrew Dunn takes us through the myriad…

In this week’s episode we speak with Bailey Lipschultz of Bloomberg to discuss the outlook for the biotech industry and the industry’s recent winners and losers in these turbulent markets. TRANSCRIPT Jeffrey Friedman: Hello, and…

In this week’s interview we speak with Shawn Tully, Senior Editor At Large for Fortune Magazine, where we discuss the intersection of public policy, public health and government spending as it relates to the coronavirus…

In this week’s episode, we speak with Sara Harrison of Wired.  Sara discusses the issues our senior population have with the coronavirus and why they are more at risk for serious health complications than the…